136 related articles for article (PubMed ID: 30913894)
41. The Relationship Between Peripheral Artery Disease Symptomatology and Ischemia.
Schorr EN; Treat-Jacobson D; Lindquist R
Nurs Res; 2017; 66(5):378-387. PubMed ID: 28858146
[TBL] [Abstract][Full Text] [Related]
42. Calf muscle oxygen saturation and the effects of supervised exercise training for intermittent claudication.
Beckitt TA; Day J; Morgan M; Lamont PM
J Vasc Surg; 2012 Aug; 56(2):470-5. PubMed ID: 22503174
[TBL] [Abstract][Full Text] [Related]
43. Tissue (muscle) oxygen saturation (StO2): a new measure of symptomatic lower-extremity arterial disease.
Comerota AJ; Throm RC; Kelly P; Jaff M
J Vasc Surg; 2003 Oct; 38(4):724-9. PubMed ID: 14560221
[TBL] [Abstract][Full Text] [Related]
44. High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy.
Greiner A; Esterhammer R; Messner H; Biebl M; Mühlthaler H; Fraedrich G; Jaschke WR; Schocke MF
J Vasc Surg; 2006 May; 43(5):978-86. PubMed ID: 16678693
[TBL] [Abstract][Full Text] [Related]
45. Calf raise exercise increases walking performance in patients with intermittent claudication.
Van Schaardenburgh M; Wohlwend M; Rognmo Ø; Mattsson E
J Vasc Surg; 2017 May; 65(5):1473-1482. PubMed ID: 28285932
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of functional capacity and muscle metabolism in individuals with peripheral arterial disease with and without diabetes.
Paulino Geisel P; Pantuso Monteiro D; de Oliveira Nascimento I; Gomes Pereira DA
J Vasc Surg; 2022 Feb; 75(2):671-679. PubMed ID: 34921971
[TBL] [Abstract][Full Text] [Related]
47. Monitored daily ambulatory activity, inflammation, and oxidative stress in patients with claudication.
Gardner AW; Parker DE; Montgomery PS; Blevins SM; Teague AM; Casanegra AI
Angiology; 2014 Jul; 65(6):491-6. PubMed ID: 23695338
[TBL] [Abstract][Full Text] [Related]
48. Graduated Compression Stockings Does Not Decrease Walking Capacity and Muscle Oxygen Saturation during 6-Minute Walk Test in Intermittent Claudication Patients.
Cavalcante BR; Ritti-Dias RM; Germano Soares AH; Domingues WJR; Saes GF; Duarte FH; da Cruz AP; Wolosker N; Puech-Leão P; Cucato GG; Zerati AE
Ann Vasc Surg; 2017 Apr; 40():239-242. PubMed ID: 27932292
[TBL] [Abstract][Full Text] [Related]
49. Acute effects of leg heat therapy on walking performance and cardiovascular and inflammatory responses to exercise in patients with peripheral artery disease.
Monroe JC; Song Q; Emery MS; Hirai DM; Motaganahalli RL; Roseguini BT
Physiol Rep; 2021 Jan; 8(24):e14650. PubMed ID: 33369253
[TBL] [Abstract][Full Text] [Related]
50. A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease.
Russell KS; Yates DP; Kramer CM; Feller A; Mahling P; Colin L; Clough T; Wang T; LaPerna L; Patel A; Lawall H; Shennak MM; Fulmer J; Nikol S; Smith WB; Müller OJ; Ratchford EV; Basson CT
Vasc Med; 2019 Oct; 24(5):414-421. PubMed ID: 31277561
[TBL] [Abstract][Full Text] [Related]
51. The effect of hypercholestrolemia on calf muscle hemoglobin oxygen saturation in patients with intermittent claudication.
Afaq A; Montgomery PS; Scott KJ; Blevins SM; Whitsett TL; Gardner AW
Angiology; 2008; 59(5):534-41. PubMed ID: 18388089
[TBL] [Abstract][Full Text] [Related]
52. Effects of sildenafil on maximum walking time in patients with arterial claudication: The ARTERIOFIL study.
Omarjee L; Le Pabic E; Custaud MA; Fontaine C; Locher C; Renault A; Jaquinandi V; Azzola V; Barbeau-Terrier C; Laporte I; Ripoche M; Onillon Y; Chretien JM; Daniel V; Chao de la Barca JM; Homedan C; Reynier P; Abraham P; Mahé G
Vascul Pharmacol; 2019; 118-119():106563. PubMed ID: 31152977
[TBL] [Abstract][Full Text] [Related]
53. Association between gait characteristics and endothelial oxidative stress and inflammation in patients with symptomatic peripheral artery disease.
Gardner AW; Montgomery PS; Casanegra AI; Silva-Palacios F; Ungvari Z; Csiszar A
Age (Dordr); 2016 Jun; 38(3):64. PubMed ID: 27273077
[TBL] [Abstract][Full Text] [Related]
54. Clinical application of transcutaneous oxygen pressure measurements during exercise.
Abraham P; Gu Y; Guo L; Kroeger K; Ouedraogo N; Wennberg P; Henni S
Atherosclerosis; 2018 Sep; 276():117-123. PubMed ID: 30059842
[TBL] [Abstract][Full Text] [Related]
55. Acute effects of walking and combined exercise on oxidative stress and vascular function in peripheral artery disease.
Lima AHRA; Correia MA; Soares AHG; Farah BQ; Forjaz CLM; Silva AS; Brasileiro-Santos MS; Santos AC; Ritti-Dias RM
Clin Physiol Funct Imaging; 2018 Jan; 38(1):69-75. PubMed ID: 27491344
[TBL] [Abstract][Full Text] [Related]
56. Impaired hemodynamic response to exercise in patients with peripheral artery disease: evidence of a link to inflammation and oxidative stress.
Craig JC; Hart CR; Layec G; Kwon OS; Richardson RS; Trinity JD
Am J Physiol Regul Integr Comp Physiol; 2022 Nov; 323(5):R710-R719. PubMed ID: 36154490
[TBL] [Abstract][Full Text] [Related]
57. Effects of Long-Term Home Exercise in Participants With Peripheral Artery Disease.
Gardner AW; Montgomery PS; Wang M; Liang M
J Am Heart Assoc; 2023 Nov; 12(21):e029755. PubMed ID: 37929770
[TBL] [Abstract][Full Text] [Related]
58. Oxygen saturation measurement of calf muscle during exercise in intermittent claudication.
Komiyama T; Onozuka A; Miyata T; Shigematsu H
Eur J Vasc Endovasc Surg; 2002 May; 23(5):388-92. PubMed ID: 12027464
[TBL] [Abstract][Full Text] [Related]
59. Moderate-pain versus pain-free exercise, walking capacity, and cardiovascular health in patients with peripheral artery disease.
Novaković M; Krevel B; Rajkovič U; Vižintin Cuderman T; Janša Trontelj K; Fras Z; Jug B
J Vasc Surg; 2019 Jul; 70(1):148-156. PubMed ID: 30922760
[TBL] [Abstract][Full Text] [Related]
60. Transcutaneous calf-muscle electro-stimulation: A prospective treatment for diabetic claudicants?
Ellul C; Gatt A
Diab Vasc Dis Res; 2016 Nov; 13(6):442-444. PubMed ID: 27543326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
